|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:1270-1279
© 2008 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
b Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio
c Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
Received for publication May 2, 2007; revisions received November 29, 2007; accepted for publication December 18, 2007. * Address for reprints: Tomislav Mihaljevic, MD, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Avenue/Desk F24, Cleveland, OH 44195. (Email: mihaljt{at}ccf.org).
Objective: Recommendations for aortic valve replacement in severe aortic stenosis are based primarily on the presence of symptoms. However, the onset of symptoms is often insidious, potentially leading to delayed intervention and suboptimal results. Identifying factors that reduce the survival of patients undergoing aortic valve replacement could lead to revised treatment guidelines and improved outcomes.
Methods: We conducted a single-center observational clinical study of 3049 patients with aortic stenosis who underwent native aortic valve replacement with a single type of bioprosthesis. The primary end point was all-cause mortality from the date of operation. Multivariable analysis of risk factors for death was performed in the multiphase hazard function domain.
Results: The presence of severe left ventricular hypertrophy at operation, which preceded symptoms in 17% of patients, was associated with decreased survival. This effect was magnified by the severity of aortic stenosis (P = .02) and use of small prostheses (P = .01). The presence of left ventricular dysfunction reduced survival (P = .0003). Although older age was a risk factor for death (P < .0001), elderly patients had survival comparable to their age, race, and sex-matched cohorts, whereas younger patients had worse than expected survival that was further diminished with insertion of a small prosthesis (P = .01).
Conclusion: To optimize survival, earlier aortic valve replacement should be considered even in asymptomatic patients before severe left ventricular hypertrophy or dysfunction develops. In younger patients, the largest possible prosthesis should be implanted to minimize residual gradient; in elderly patients, complex operations just to insert larger prostheses should be avoided.
Related Article
J. Thorac. Cardiovasc. Surg. 2008 135: 1278-1279.
This article has been cited by other articles:
![]() |
M. Di Eusanio, D. Fortuna, D. Cristell, P. Pugliese, F. Nicolini, D. Pacini, D. Gabbieri, M. Lamarra, and on behalf of RERIC (Emilia Romagna Cardiac Surgery Contemporary outcomes of conventional aortic valve replacement in 638 octogenarians: insights from an Italian Regional Cardiac Surgery Registry (RERIC) Eur J Cardiothorac Surg, January 12, 2012; (2012) ezr204v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Eusanio and D. Fortuna Reply to the editor. J. Thorac. Cardiovasc. Surg., November 1, 2011; 142(5): 1290 - 1290. [Full Text] [PDF] |
||||
![]() |
J. Higgins, W. R. E. Jamieson, O. Benhameid, J. Ye, A. Cheung, P. Skarsgard, E. Germann, F. Chan, and S. V. Lichtenstein Influence of patient gender on mortality after aortic valve replacement for aortic stenosis J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 595 - 601.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Dahl, L. Videbaek, M. K. Poulsen, P. A. Pellikka, K. Veien, L. I. Andersen, T. Haghfelt, and J. E. Moller Noninvasive assessment of filling pressure and left atrial pressure overload in severe aortic valve stenosis: Relation to ventricular remodeling and clinical outcome after aortic valve replacement J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): e77 - e83. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gada, P. A. Scuffham, B. Griffin, and T. H. Marwick Quality-of-Life Implications of Immediate Surgery and Watchful Waiting in Asymptomatic Aortic Stenosis: A Decision-Analytic Model Circ Cardiovasc Qual Outcomes, September 1, 2011; 4(5): 541 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Knoll, G. Iaccarino, G. Tarone, D. Hilfiker-Kleiner, J. Bauersachs, A. F. Leite-Moreira, P. H. Sugden, and J.-L. Balligand Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC Eur J Heart Fail, August 1, 2011; 13(8): 811 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Villar, D. Merino, M. Wenner, M. Llano, M. Cobo, C. Montalvo, R. Garcia, R. Martin-Duran, J. M. Hurle, M. A. Hurle, et al. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis Heart, July 15, 2011; 97(14): 1132 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Lindman, S. V. Arnold, J. A. Madrazo, A. Zajarias, S. N. Johnson, J. E. Perez, and D. L. Mann The Adverse Impact of Diabetes Mellitus on Left Ventricular Remodeling and Function in Patients With Severe Aortic Stenosis Circ Heart Fail, May 1, 2011; 4(3): 286 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Eusanio, D. Fortuna, R. De Palma, A. Dell'Amore, M. Lamarra, G. A. Contini, T. Gherli, D. Gabbieri, I. Ghidoni, D. Cristell, et al. Aortic valve replacement: Results and predictors of mortality from a contemporary series of 2256 patients J. Thorac. Cardiovasc. Surg., April 1, 2011; 141(4): 940 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Benedetto, G. Melina, S. Refice, R. di Bartolomeo, A. Roscitano, E. Angeloni, and R. Sinatra Dual Renin-Angiotensin System Blockade for Patients With Prosthesis-Patient Mismatch Ann. Thorac. Surg., December 1, 2010; 90(6): 1899 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ngaage, J. Dickson, and L. Guvendik Does Aortic Valve Replacement Mitigate the Risk of Preoperative Heart Failure? Asian Cardiovasc Thorac Ann, December 1, 2010; 18(6): 541 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A. Chang, P.-W. Park, K. Sung, S.-C. Lee, S. W. Park, Y. T. Lee, and J. K. Oh Noninvasive estimate of left ventricular filling pressure correlated with early and midterm postoperative cardiovascular events after isolated aortic valve replacement in patients with severe aortic stenosis J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6): 1361 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Halkos, P. Kilgo, O. M. Lattouf, J. D. Puskas, W. A. Cooper, R. A. Guyton, and V. H. Thourani The Effect of Diabetes Mellitus on In-Hospital and Long-Term Outcomes After Heart Valve Operations Ann. Thorac. Surg., July 1, 2010; 90(1): 124 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Flameng, M. C. Herregods, M. Vercalsteren, P. Herijgers, K. Bogaerts, and B. Meuris Prosthesis-Patient Mismatch Predicts Structural Valve Degeneration in Bioprosthetic Heart Valves Circulation, May 18, 2010; 121(19): 2123 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakai, M. Takeuchi, H. Yoshitani, K. Kaku, N. Haruki, and Y. Otsuji Pitfalls of anatomical aortic valve area measurements using two-dimensional transoesophageal echocardiography and the potential of three-dimensional transoesophageal echocardiography Eur Heart J Cardiovasc Imaging, May 1, 2010; 11(4): 369 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Benedetto, G. Melina, E. Angeloni, S. Refice, G. Scafani, A. Roscitano, E. Tonelli, and R. Sinatra Moderate chronic kidney disease and left ventricular hypertrophy after aortic valve replacement for aortic valve stenosis. J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 881 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Bakaeen, D. Chu, M. Ratcliffe, R. R. Gopaldas, A. S. Blaustein, R. Venkat, J. Huh, S. A. LeMaire, J. S. Coselli, and B. A. Carabello Severe Aortic Stenosis in a Veteran Population: Treatment Considerations and Survival Ann. Thorac. Surg., February 1, 2010; 89(2): 453 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pibarot and J. G Dumesnil Longitudinal myocardial shortening in aortic stenosis: ready for prime time after 30 years of research? Heart, January 15, 2010; 96(2): 95 - 96. [Full Text] [PDF] |
||||
![]() |
V. Delgado, L. F. Tops, R. J. van Bommel, F. van der Kley, N. A. Marsan, R. J. Klautz, M. I.M. Versteegh, E. R. Holman, M. J. Schalij, and J. J. Bax Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement Eur. Heart J., December 2, 2009; 30(24): 3037 - 3047. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hachicha, J. G. Dumesnil, and P. Pibarot Usefulness of the Valvuloarterial Impedance to Predict Adverse Outcome in Asymptomatic Aortic Stenosis J. Am. Coll. Cardiol., September 8, 2009; 54(11): 1003 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schoenhagen, E. M. Tuzcu, S. R. Kapadia, M. Y. Desai, and L. G. Svensson Three-dimensional imaging of the aortic valve and aortic root with computed tomography: new standards in an era of transcatheter valve repair/implantation Eur. Heart J., September 1, 2009; 30(17): 2079 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Hannan, Z. Samadashvili, S. J. Lahey, C. R. Smith, A. T. Culliford, R. S.D. Higgins, J. P. Gold, and R. H. Jones Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Ann. Thorac. Surg., June 1, 2009; 87(6): 1741 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908. [Full Text] [PDF] |
||||
![]() |
S. Leontyev, T. Walther, M. A. Borger, S. Lehmann, A. K. Funkat, A. Rastan, J. Kempfert, V. Falk, and F. W. Mohr Aortic Valve Replacement in Octogenarians: Utility of Risk Stratification With EuroSCORE Ann. Thorac. Surg., May 1, 2009; 87(5): 1440 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thomas Trans-catheter aortic valve implantation in the United Kingdom: NICE guidance Heart, April 1, 2009; 95(8): 674 - 675. [Full Text] [PDF] |
||||
![]() |
B. R. Osswald, V. Gegouskov, D. Badowski-Zyla, U. Tochtermann, G. Thomas, S. Hagl, and E. H. Blackstone Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement Eur. Heart J., January 1, 2009; 30(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garcia, P. G. Camici, L.-G. Durand, K. Rajappan, E. Gaillard, O. E. Rimoldi, and P. Pibarot Impairment of coronary flow reserve in aortic stenosis J Appl Physiol, January 1, 2009; 106(1): 113 - 121. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |